Navigation Links
New Survey Underscores Importance of Psychosocial and Educational Needs Among Women with Advanced Breast Cancer

- Survey Data Also Underscores Dissatisfaction with Treatment Experience,

Importance of Internet as Informational Resource -

SAN ANTONIO, Dec. 16 /PRNewswire/ -- Psychosocial support in women with advanced or metastatic breast cancer (MBC) is as important as the need for disease- and treatment-related information, according to results of a survey presented here today at the 30th Annual San Antonio Breast Cancer Symposium.

The survey of 367 women with advanced breast cancer, which was conducted by Y-ME National Breast Cancer Organization, also underscores the growing importance of the Internet as an information resource for patients. The survey uncovered that patients with MBC feel that the Internet can be utilized more effectively by healthcare professionals and patient advocates.

"Despite the growing recognition of unmet medical, educational, and psychosocial needs among women with advanced breast cancer, there has been little information regarding which of these needs are most important to this patient population," said Margaret C. Kirk, CEO, Y-ME National Breast Cancer Organization. "This survey identifies psychosocial support as a high priority for women with metastatic breast cancer, one that should be pursued in tandem with the search for more effective and better-tolerated treatments."

Additionally, survey participants' responses about treatment-related side effects, fears and anxieties, and the overall treatment experience suggest that healthcare professionals would benefit from more education.

Survey Highlights Negative Experiences with Disease and Treatment

The survey identified a host of challenges among women with MBC. A vast majority (94%) of respondents indicated that they had experienced weakness or fatigue while dealing with their disease; and nearly three-quarters (73%) said they had suffered from depression. Two-thirds (67%) noted they had experienced cognitive disorders associated with treatment (e.g., the so-called "chemo-brain" syndrome); and more than half (51%) complained of sexual dysfunction. When asked what has concerned them most about their treatment, nearly one-third of survey participants mentioned side effects (29%), fear that the treatment would not work (29%) and fear of the unknown (27%). Respondents noted that fatigue (30%) was the most impactful of side effects associated with standard treatment, followed by pain (21%) and hair loss (14%).

When the survey participants were asked who has given them the most support in dealing with MBC, family member (43%) was mentioned most often, followed by caregiver (16%), friend (14%), and medical oncologist (13%). Nearly as many respondents said they get most of their information about MBC from the Internet (39%) as from their doctors (42%), and 86 percent said Web- based MBC education and support materials would be most helpful to them.

The survey uncovered gaps in the treatment of MBC. Twenty-two percent expressed unhappiness with the care they have received for their disease; 73% were not offered entry into a clinical trial at diagnosis; 36% disagreed with the statement that women with MBC have a variety of treatment options available to them; 41% indicated that options were not clear to them at the time of diagnosis; and 52% said their healthcare provider does not offer a variety of treatment options or keep them informed of relevant drug approvals and clinical trials.

The survey also uncovered a strong desire for more patient advocacy groups to focus on MBC, as voiced by 82% of respondents. Nearly half of those polled (47%) expressed a wish for more monetary support in the area of MBC research to extend survival.

"Although the breast cancer advocacy communities have made great strides in developing and disseminating information about metastatic breast cancer, it is clear that we need to do a better job in these areas," said Kirk. "The survey results should serve as a wake-up call to healthcare professionals and advocacy groups to step up and improve their communication and support to patients, caregivers, and families dealing with this devastating disease."

About Y-ME

Y-ME's mission is to ensure, through information, empowerment and peer support, that no one faces breast cancer alone. Y-ME does not raise money for research but is here today for those who can't wait for tomorrow's cure. Y-ME has the only 24-hour hotline staffed entirely by trained breast cancer survivors.

Y-ME is a 501(c)(3) and meets the National Health Council's 41 Standards of Excellence in governance, fundraising, accounting and reporting, and evaluation.

For information or support, visit or call 1-800-221- 2141 (English, with interpreters available in 150 languages) or 1-800-986-9505 (Spanish).

SOURCE Y-ME National Breast Cancer Organization
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Survey reveals disparities in skin cancer knowledge, protection among high school students
2. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
5. Youth Drug Use at a Five Year Low, New Survey Shows
6. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
7. Parental surveys boost diagnosis abilities of pediatricians
8. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
9. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
10. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
11. Launch of second European Cancer Research Funding survey
Post Your Comments:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... is offering lower prices in an early celebration of the early holiday shopping ... price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 Endo International plc (NASDAQ: ENDP ... , President and CEO, will discuss corporate updates at the ... New York on Wednesday, December 2, 2015 ... on Investor Relations, and then the link to the event. ... start time to visit the site and download any streaming ...
(Date:11/25/2015)... 2015 Asia -based ... BioLight and the New Investors will make a direct ... a private placement. The financing will help IOPtima to ... used in the treatment of glaucoma, as well as ... IOPtimate™ system with the U.S. Food and Drug Administration, ...
(Date:11/25/2015)... 2015 - Will Also Offer ... (CME) --> - Will Also ... (CME) --> - Will ... Medical Education (CME) Elsevier , a ... will feature latest diagnostic imaging textbooks and decision support tools, as ...
Breaking Medicine Technology: